These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5382022)

  • 1. [Blood level course in humans following administration of 2 various kinds of L-asparaginase].
    Pütter J; Gehrmann G
    Klin Wochenschr; 1969 Dec; 47(24):1324-6. PubMed ID: 5382022
    [No Abstract]   [Full Text] [Related]  

  • 2. L-asparaginase activity in plasma and other biological fluids.
    Schwartz MK; Lash ED; Oettgen HF; Tomato FA
    Cancer; 1970 Feb; 25(2):244-52. PubMed ID: 4905152
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of L-asparaginase. Introduction.
    Burchenal JH; Karnofsky DA
    Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to highly purified L-asparaginase during therapy of acute leukemia.
    Hill JM; Loeb E; MacLellan A; Khan A; Roberts J; Shields WF; Hill NO
    Cancer Res; 1969 Aug; 29(8):1574-80. PubMed ID: 4896902
    [No Abstract]   [Full Text] [Related]  

  • 5. Biocmical and pharmacologic effects of L-asparaginase in man.
    Haskell CM; Canellos GP; Cooney DA; Hansen HH
    J Lab Clin Med; 1970 May; 75(5):763-70. PubMed ID: 4909251
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
    Siu Chong ED; Chang TM
    Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of exogenous and endogenous L-asparaginase in mice].
    Wierer U; Pütter J
    Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic behavior of L-asparaginase in men and in animals.
    Pütter J
    Recent Results Cancer Res; 1970; 33():64-74. PubMed ID: 5526349
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology of intramuscularly administered L-asparaginase.
    Ho DH; Yap HY; Brown N; Benjamin RS; Friereich EJ; Blumenschein GR; Bodey GP
    J Clin Pharmacol; 1981; 21(2):72-8. PubMed ID: 7229120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [L-asparaginase in advanced acute leukemia in children].
    Armata J; Wyszkowski J; Cyklis R; Zajaczkowski J; Depowska T
    Pol Tyg Lek; 1971 May; 26(22):826-8. PubMed ID: 5091029
    [No Abstract]   [Full Text] [Related]  

  • 11. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parameters for the clinical use of L-asparaginase].
    Mistretta AP; Astaldi G; Tassi GC; DeBarbieri A
    Ann Ist Super Sanita; 1971; 7(2):405-7. PubMed ID: 5154664
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimenting with the use of L-asparaginase in the treatment of neoplasms of the blood system].
    Lorie IuI; Kruglova GV; Poddubnaia IV; Mansurov AN
    Klin Med (Mosk); 1973 Jun; 51(6):52-8. PubMed ID: 4774561
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antitumor activity of L-asparaginase].
    Adamson RH; Fabro S
    Acta Vitaminol Enzymol; 1969; 23(3):111-24. PubMed ID: 4897937
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
    Nesbit M; Chard R; Evans A; Karon M; Hammond GD
    Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-asparaginase in the treatment of leukemia].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtini E; Bruschelli M; Astaldi A
    Przegl Lek; 1971; 27(3):286-9. PubMed ID: 5280473
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempts at treatment of acute leukemia with L-asparaginase].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
    Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of malignant human neoplasms with L-asparaginase].
    Oettgen HF; Schulten HK
    Klin Wochenschr; 1969 Jan; 47(2):65-71. PubMed ID: 4904782
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
    Haskell CM; Canellos GP; Cooney DA; Hardesty CT
    Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic tumor sensitivity to plasma L-asparagine starvation.
    Dufour E; Gay F; Aguera K; Scoazec JY; Horand F; Lorenzi PL; Godfrin Y
    Pancreas; 2012 Aug; 41(6):940-8. PubMed ID: 22513289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.